SUPPORT HOTLINE 888-901-2226
Donate Now

BCAN Updates

Approval For The First-Ever Targeted Therapy For Metastatic Bladder Cancer

Janessen has announced its drug  BALVERSA or erdafitinib has received accelerated approval from the FDA “for the treatment of adults with locally advanced or metastatic urothelial carcinoma.” Stephanie Chisolm, PhD, BCAN’s Director of Education and Research said, “This new treatment option is wonderful news for patients with metastatic bladder cancer. We

Read More

Light the Month Orange

We are almost at Bladder Cancer Awareness Month, and we have LOTS of activities and resources – local and national – to tell you about.   Like last year, we are coordinating orange illuminations of landmarks across the country to create more awareness about bladder cancer. For example, on May

Read More